Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial.
Br J Cancer
; 130(2): 233-241, 2024 02.
Article
in En
| MEDLINE
| ID: mdl-37996507
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
Limits:
Humans
Language:
En
Journal:
Br J Cancer
Year:
2024
Document type:
Article
Affiliation country:
Alemania
Country of publication:
Reino Unido